vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and WESBANCO INC (WSBC). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $257.2M, roughly 2.0× WESBANCO INC). WESBANCO INC runs the higher net margin — 34.5% vs -12.3%, a 46.8% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 31.9%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

WesBanco, Inc., is a bank holding company headquartered in Wheeling, West Virginia, United States. It has over 200 branches in West Virginia, Ohio, Western Pennsylvania, Kentucky, Maryland, and Southern Indiana.

GENI vs WSBC — Head-to-Head

Bigger by revenue
GENI
GENI
2.0× larger
GENI
$510.9M
$257.2M
WSBC
Higher net margin
WSBC
WSBC
46.8% more per $
WSBC
34.5%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
31.9%
WSBC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GENI
GENI
WSBC
WSBC
Revenue
$510.9M
$257.2M
Net Profit
$-63.0M
$88.6M
Gross Margin
25.2%
Operating Margin
-11.5%
Net Margin
-12.3%
34.5%
Revenue YoY
Net Profit YoY
54.4%
EPS (diluted)
$0.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
WSBC
WSBC
Q1 26
$257.2M
Q4 25
$510.9M
$265.6M
Q3 25
$335.4M
$261.6M
Q2 25
$215.2M
$260.7M
Q1 25
$119.7M
$193.2M
Q4 24
$413.0M
$162.9M
Q3 24
$285.8M
$150.8M
Q2 24
$184.1M
$147.9M
Net Profit
GENI
GENI
WSBC
WSBC
Q1 26
$88.6M
Q4 25
$-63.0M
$91.1M
Q3 25
$83.6M
Q2 25
$-47.3M
$57.4M
Q1 25
$-25.5M
$-9.0M
Q4 24
$-85.5M
$49.6M
Q3 24
$-47.1M
$37.3M
Q2 24
$-35.5M
$28.9M
Gross Margin
GENI
GENI
WSBC
WSBC
Q1 26
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Operating Margin
GENI
GENI
WSBC
WSBC
Q1 26
Q4 25
-11.5%
43.2%
Q3 25
-15.3%
39.5%
Q2 25
-21.0%
27.2%
Q1 25
-20.3%
-5.0%
Q4 24
-18.0%
38.0%
Q3 24
-13.9%
29.7%
Q2 24
-16.8%
23.7%
Net Margin
GENI
GENI
WSBC
WSBC
Q1 26
34.5%
Q4 25
-12.3%
34.3%
Q3 25
31.9%
Q2 25
-22.0%
22.0%
Q1 25
-21.3%
-4.7%
Q4 24
-20.7%
30.5%
Q3 24
-16.5%
24.7%
Q2 24
-19.3%
19.5%
EPS (diluted)
GENI
GENI
WSBC
WSBC
Q1 26
$0.88
Q4 25
$0.97
Q3 25
$0.84
Q2 25
$0.57
Q1 25
$-0.15
Q4 24
$0.72
Q3 24
$0.54
Q2 24
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
WSBC
WSBC
Cash + ST InvestmentsLiquidity on hand
$280.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$724.5M
$4.1B
Total Assets
$1.1B
$27.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
WSBC
WSBC
Q1 26
Q4 25
$280.6M
$956.1M
Q3 25
$110.2M
$1.0B
Q2 25
$110.2M
$1.2B
Q1 25
$110.2M
$1.1B
Q4 24
$100.3M
$568.1M
Q3 24
$100.3M
$620.9M
Q2 24
$100.3M
$486.8M
Stockholders' Equity
GENI
GENI
WSBC
WSBC
Q1 26
$4.1B
Q4 25
$724.5M
$4.0B
Q3 25
$572.4M
$4.1B
Q2 25
$572.4M
$3.8B
Q1 25
$572.4M
$3.8B
Q4 24
$573.0M
$2.8B
Q3 24
$573.0M
$2.8B
Q2 24
$573.0M
$2.5B
Total Assets
GENI
GENI
WSBC
WSBC
Q1 26
$27.5B
Q4 25
$1.1B
$27.7B
Q3 25
$792.3M
$27.5B
Q2 25
$792.3M
$27.6B
Q1 25
$792.3M
$27.4B
Q4 24
$775.7M
$18.7B
Q3 24
$775.7M
$18.5B
Q2 24
$775.7M
$18.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
WSBC
WSBC
Operating Cash FlowLast quarter
$81.9M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
WSBC
WSBC
Q1 26
Q4 25
$81.9M
$290.4M
Q3 25
$-4.8M
$116.9M
Q2 25
$-1.2M
$105.0M
Q1 25
$-14.6M
$-26.4M
Q4 24
$14.9M
$211.0M
Q3 24
$-9.2M
$60.7M
Q2 24
$18.2M
Free Cash Flow
GENI
GENI
WSBC
WSBC
Q1 26
Q4 25
$69.6M
$280.0M
Q3 25
$-14.2M
$114.9M
Q2 25
$-5.8M
$98.3M
Q1 25
$-16.0M
$-30.7M
Q4 24
$11.3M
$200.7M
Q3 24
$-11.6M
$56.9M
Q2 24
$17.3M
FCF Margin
GENI
GENI
WSBC
WSBC
Q1 26
Q4 25
13.6%
105.4%
Q3 25
-4.2%
43.9%
Q2 25
-2.7%
37.7%
Q1 25
-13.4%
-15.9%
Q4 24
2.7%
123.2%
Q3 24
-4.1%
37.7%
Q2 24
11.7%
Capex Intensity
GENI
GENI
WSBC
WSBC
Q1 26
Q4 25
2.4%
3.9%
Q3 25
2.8%
0.8%
Q2 25
2.1%
2.6%
Q1 25
1.2%
2.2%
Q4 24
0.9%
6.3%
Q3 24
0.9%
2.5%
Q2 24
0.6%
Cash Conversion
GENI
GENI
WSBC
WSBC
Q1 26
Q4 25
3.19×
Q3 25
1.40×
Q2 25
1.83×
Q1 25
Q4 24
4.25×
Q3 24
1.63×
Q2 24
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

WSBC
WSBC

Net Interest Income$215.4M84%
Noninterest Income$41.8M16%

Related Comparisons